Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Luca Baldini
University of Milan
Via Festa del Perdono, 7
Milan, 20122
Italy
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
59
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Bortezomib, Cyclophosphamide, Dexamethasone Versus Lenalidomide, Cyclophosphamide, Dexamethasone in Multiple Myeloma Patients at First Relapse
Number of pages: 100
Posted: 10 Nov 2018
Vittorio Montefusco
,
Alessandro Corso
,
Monica Galli
,
Ilaria Ardoino
,
Sara Pezzatti
,
Cristina Carniti
,
Francesca Patriarca
,
Filippo Gherlinzoni
,
Renato Zambello
,
Simona Sammassimo
,
Magda Marcatti
,
Andrea Nozza
,
Claudia Crippa
,
Anna Maria Cafro
, Luca Baldini and
Paolo Corradini
Fondazione IRCCS Istituto Nazionale dei Tumori - Division of Hematology and Bone Marrow Transplantation, Fondazione IRCCS Policlinico San Matteo, Papa Giovanni XXIII Hospital, Istituto di Ricerche Farmacologiche, Università degli Studi di Milano-Bicocca - Fondazione MBBM/San Gerardo Hospital, Fondazione IRCCS Istituto Nazionale dei Tumori, Università degli Studi di Udine, Hematology, Ca’ Foncello Hospital, University of Padua, European Institute of Oncology (IEO) IRCCS, Università Vita-Salute San Raffaele - IRCCS San Raffaele Scientific Institute, Istituto Clinico Humanitas, ASST-Spedali Civili of Brescia, Niguarda Ca' Granda Hospital, University of Milan and University of Milan
Downloads
59
(970,490)
View PDF
Download
Abstract:
Multiple myeloma,lenalidomide, bortezomib
Feedback
